Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the Revision: v3.4.1 notice regarding government funding status.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision information to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' toggle and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor revision label update: Revision: v3.3.4 now appears where Revision: v3.3.3 was shown, with no impact on study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link along with the prior Revision: v3.3.2 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all be about the study. Page revision updated to v3.3.2, replacing the older wording about PubMed-derived listings.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.